Literature DB >> 12196529

Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression.

Zhao Mei Mu1, Xiao Ying Yin, Edward V Prochownik.   

Abstract

The highly conserved Myc Box II (MBII) domain of c-Myc is critically important for transformation and transcriptional regulation. A yeast two-hybrid screen identified Pag as a MBII-interacting protein. Pag, a member of the peroxiredoxin family, has been reported previously to bind to and inhibit the cytostatic properties of the c-Abl oncoprotein. We now show that Pag promotes increased cell size and confers a proapoptotic phenotype, two hallmark features of ectopic c-Myc overexpression. Pag and c-Myc also confer resistance to oxidative stress, a previously unrecognized property of the latter protein. In contrast, Pag inhibits tumorigenesis by c-Myc-overexpressing fibroblasts and causes a broad but selective loss of c-Myc target gene regulation. Pag is therefore an MBII-interacting protein that can either mimic or enhance some of the c-Myc properties while at the same inhibiting others. These features, along with the previously identified interaction with c-Abl, provide support for the idea that Pag functions as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196529     DOI: 10.1074/jbc.M206066200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells.

Authors:  Lianqin Li; Ai-Qun Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-21       Impact factor: 4.553

2.  The 2-Cys peroxiredoxin alkyl hydroperoxide reductase c binds heme and participates in its intracellular availability in Streptococcus agalactiae.

Authors:  Delphine Lechardeur; Annabelle Fernandez; Bruno Robert; Philippe Gaudu; Patrick Trieu-Cuot; Gilles Lamberet; Alexandra Gruss
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

3.  Identification of differentially regulated secretome components during skeletal myogenesis.

Authors:  C Y X'avia Chan; Olena Masui; Olga Krakovska; Vladimir E Belozerov; Sebastien Voisin; Shaun Ghanny; Jian Chen; Dharsee Moyez; Peihong Zhu; Kenneth R Evans; John C McDermott; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2011-02-22       Impact factor: 5.911

4.  Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.

Authors:  Jung Mi Byun; Su Sun Kim; Ki Tae Kim; Mi Seon Kang; Dae Hoon Jeong; Dae Sim Lee; Eun Jung Jung; Young Nam Kim; Jin Han; In Sung Song; Kyoun Bok Lee; Moon Su Sung
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

Review 5.  Signaling functions of reactive oxygen species.

Authors:  Henry Jay Forman; Matilde Maiorino; Fulvio Ursini
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

6.  ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Jinghe Li; Zhu-Lin Yang; Xuebao Ren; Qiong Zou; Yuan Yuan; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Tumour Biol       Date:  2012-10-13

7.  Human peroxiredoxin PrxI is an orthologue of yeast Tsa1, capable of suppressing genome instability in Saccharomyces cerevisiae.

Authors:  Ismail Iraqui; Gérard Faye; Sandrine Ragu; Amélie Masurel-Heneman; Richard D Kolodner; Meng-Er Huang
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

8.  Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies.

Authors:  Qiou Wei; Hong Jiang; Connie P Matthews; Nancy H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

9.  Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Authors:  J Anthony Graves; Kristi Rothermund; Tao Wang; Wei Qian; Bennett Van Houten; Edward V Prochownik
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  Novel protective mechanism against irreversible hyperoxidation of peroxiredoxin: Nalpha-terminal acetylation of human peroxiredoxin II.

Authors:  Jae Ho Seo; Jung Chae Lim; Duck-Yeon Lee; Kyung Seok Kim; Grzegorz Piszczek; Hyung Wook Nam; Yu Sam Kim; Taeho Ahn; Chul-Ho Yun; Kanghwa Kim; P Boon Chock; Ho Zoon Chae
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.